Neurogene Inc. (NASDAQ: NGNE) Stock Information | RedChip

Neurogene Inc. (NASDAQ: NGNE)


$18.0350
+2.4450 ( +16.51% ) 360.5K

Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.

Market Data


Open


$18.0350

Previous close


$15.5900

Volume


360.5K

Market cap


$231.59M

Day range


$14.6970 - $18.3980

52 week range


$12.4900 - $74.4900

SEC Filings


Form Type Description Pages Date
8-k 8K-related 51 Jun 21, 2024
8-k 8K-related 15 Jun 18, 2024
8-k 8K-related 13 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
8-k 8K-related 15 Jun 03, 2024
10-q Quarterly Reports 80 May 10, 2024

Latest News